date:Sep 28, 2018
in 2015.
Now, drug companies are seeking to replicate that approach through medicine. Aimmune and DBV Technologies both aim to file for approval of therapies this year that seek to retrain the immune system so it doesn't overreact to peanuts. Both are examples of the new approaches to preventing potentially life-threatening reactions.
It's a huge problem, said Robert W. Baird analyst Brian Skorney, Sending kids to school, they're not allowed to bring any peanut-based food because there's almo